In-line with its multi-product strategy, Forest Laboratories Inc. announced its intentions to acquire privately held Aptalis Holdings Inc. on Jan. 8.
The $2.9 billion deal will delay new CEO Brent Saunders’ plans for a share repurchase program, but will help bolster...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?